Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BVX20

Catalog No. T9901A-1805 Copy Product Info
🥰Excellent
BVX20 is a human monoclonal antibody that binds to CD20. It can eliminate B cells by engaging the immune system. BVX20 is applicable in the study of relapsed or chemotherapy-resistant follicular B-cell non-Hodgkin lymphoma (NHL), as well as CD20-positive diffuse large B-cell non-Hodgkin lymphoma (NHL).

BVX20

Copy Product Info
🥰Excellent
Catalog No. T9901A-1805

BVX20 is a human monoclonal antibody that binds to CD20. It can eliminate B cells by engaging the immune system. BVX20 is applicable in the study of relapsed or chemotherapy-resistant follicular B-cell non-Hodgkin lymphoma (NHL), as well as CD20-positive diffuse large B-cell non-Hodgkin lymphoma (NHL).

BVX20
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
BVX20 is a human monoclonal antibody that binds to CD20. It can eliminate B cells by engaging the immune system. BVX20 is applicable in the study of relapsed or chemotherapy-resistant follicular B-cell non-Hodgkin lymphoma (NHL), as well as CD20-positive diffuse large B-cell non-Hodgkin lymphoma (NHL).
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy BVX20 | purchase BVX20 | BVX20 cost | order BVX20